Phase
Condition
Allergies & Asthma
Nasal Obstruction
Common Cold
Treatment
Mometasone furoate nasal spray (MFNS)
Matching placebo nasal spray
Clinical Study ID
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
A subject must be 12 years of age or older, of either sex, and of any race.
A subject must have at least a 2-year history of SAR which exacerbates during thestudy season.
A subject must have a positive skin prick test response to an appropriate seasonalallergen at Visit 1.
A subject must be clinically symptomatic at the Screening and Baseline Visits.
Exclusion
Exclusion Criteria:
A subject with a history of severe local reaction(s) or anaphylaxis to skin testing.
A subject who has had an upper respiratory tract or sinus infection that requiredantibiotic therapy without at least a 14-day washout prior to the Screening Visit,or who has had a viral upper respiratory infection within 7 days prior to theScreening Visit.
A subject who has used any drug in an investigational protocol in the 30 days priorto the Screening Visit.
A subject who is participating in any other clinical study.
A subject who is part of the staff personnel directly involved with this study.
A subject who is a family member (parent, spouse, or sibling) of the investigationalstudy staff.
A female subject who is breast-feeding, pregnant, or intends to become pregnant.
A subject previously randomized into this study.
A subject who has a family member (parent, spouse, or sibling) currently enrolled inthis study.